Posted on 25/02/2013

Could New AntiViral Help Flu Fight?

Could New AntiViral Help Flu Fight?

BBC suggest a promising new drug could help to fight flu

Reports from the BBC suggest that a new ‘flu drug shows promise in overcoming resistance’, stating that scientists have now found a way of permanently blocking the flu virus from spreading to other cells.

The reports were based on early stage laboratory and animal research, which set about to examine the effectiveness of a possible antiviral treatment for flu.

What other Flu antibiotics are available?

There are currently two anti-flu drugs available on the market, oseltamivir (brand name Tamiflu) and zanamivir (brand name Relenza), each blocking a viral enzyme which helps the virus infect new cells.

The widespread use of these drugs has meant the flu virus has generated a resistance to them with new drugs needed to combat evolving infections.

Working in a similar way to the existing solutions, this new drug slows down the process by which the virus spreads to new cells. In laboratory tests, researchers highlighted that the new treatments was as effective, if not more so, than Relenza, at stopping the virus from spreading to new cells. Scientists also found that it worked against flu strains that are resistant to the current drugs.

While the research is in its very early stages, the results do look promising. Further tests are required with human trials needed before it can be made available to medical professions – with this in mind, the new drug may not be available for several years.

NRS Healthcare stock a range of infection prevention products to stop bacteria and viruses from spreading. From examination gloves to hand and skin sanitisers, feel free to browse the range available on our website or contact us should you require more information.

Supplying mobility aids and disability equipment to patients and carers for over 60 years, we’re always on hand to help, providing quality products that are designed to make life easier.

Leave a Reply

You must be logged in to post a comment.